Business Description
Krka DD
ISIN : SI0031102120
Compare
Compare
Traded in other countries / regions
KRKG.SloveniaKRK.Poland0HLK.UK IPO Date
2011-05-16Description
Krka DD engages in the development, production, marketing, and sales of human health products (prescription pharmaceuticals and non-prescription products), animal health products, health resort, and tourist services. The company products in Prescription pharmaceuticals include Cardiovascular diseases, Infections, Oncology; Non-prescription products include Cold and cough products, nasal products, vitamin and minerals, hair care products; and Animal health products include Antimicrobials, Disinfectants, among others. It operates across the European Union, South-East Europe, East Europe region, and Others. The company derives a majority of revenue from the European Union.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 60.62 | |||||
| Equity-to-Asset | 0.79 | |||||
| Debt-to-Equity | 0.01 | |||||
| Debt-to-EBITDA | 0.02 | |||||
| Interest Coverage | 806.61 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 6.96 | |||||
| Beneish M-Score | -2.19 | |||||
| WACC vs ROIC | ||||||
Growth Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 6.1 | |||||
| 3-Year EBITDA Growth Rate | 2 | |||||
| 3-Year EPS without NRI Growth Rate | 2.9 | |||||
| 3-Year FCF Growth Rate | -31.7 | |||||
| 3-Year Book Growth Rate | 7.9 |
Momentum Rank
| Name | Current | Vs Industry | Vs History |
|---|
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 4.39 | |||||
| Quick Ratio | 3.07 | |||||
| Cash Ratio | 1.6 | |||||
| Days Inventory | 253.95 | |||||
| Days Sales Outstanding | 99.27 | |||||
| Days Payable | 64.65 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Dividend Growth Rate | 15.8 | |||||
| 3-Year Average Share Buyback Ratio | 0.4 | |||||
| Shareholder Yield % | 5.91 |
Profitability Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 56.1 | |||||
| Operating Margin % | 21.08 | |||||
| Net Margin % | 19.55 | |||||
| FCF Margin % | 9.33 | |||||
| ROE % | 16.41 | |||||
| ROA % | 13.02 | |||||
| ROIC % | 17.23 | |||||
| 3-Year ROIIC % | 2.99 | |||||
| ROC (Joel Greenblatt) % | 29.01 | |||||
| ROCE % | 17.89 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 11.6 | |||||
| Forward PE Ratio | 6.08 | |||||
| PE Ratio without NRI | 12.19 | |||||
| Shiller PE Ratio | 15.54 | |||||
| Price-to-Owner-Earnings | 15.78 | |||||
| PEG Ratio | 1.24 | |||||
| PS Ratio | 2.27 | |||||
| PB Ratio | 1.77 | |||||
| Price-to-Tangible-Book | 1.85 | |||||
| Price-to-Free-Cash-Flow | 24.28 | |||||
| Price-to-Operating-Cash-Flow | 13.39 | |||||
| EV-to-EBIT | 8.17 | |||||
| EV-to-EBITDA | 6.65 | |||||
| EV-to-Revenue | 1.87 | |||||
| EV-to-FCF | 20.12 | |||||
| Price-to-Projected-FCF | 0.86 | |||||
| Price-to-DCF (Earnings Based) | 0.31 | |||||
| Price-to-DCF (FCF Based) | 0.92 | |||||
| Price-to-Median-PS-Value | 1.34 | |||||
| Price-to-Peter-Lynch-Fair-Value | 1.77 | |||||
| Price-to-Graham-Number | 1 | |||||
| Price-to-Net-Current-Asset-Value | 3.09 | |||||
| Price-to-Net-Cash | 41.54 | |||||
| Earnings Yield (Greenblatt) % | 12.23 | |||||
| FCF Yield % | 4.15 | |||||
| Forward Rate of Return (Yacktman) % | 12.98 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Krka DD Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 1,871.379 | ||
| EPS (TTM) (€) | 11.85 | ||
| Beta | 0.21 | ||
| Volatility % | 11.57 | ||
| 14-Day RSI | 0 | ||
| 14-Day ATR (€) | 0.000332 | ||
| 20-Day SMA (€) | 64.8 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range (€) | 64.8 - 126 | ||
| Shares Outstanding (Mil) | 30.77 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Krka DD Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Krka DD Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Krka DD Frequently Asked Questions
What is Krka DD(LTS:0HLK)'s stock price today?
The current price of LTS:0HLK is €64.80. The 52 week high of LTS:0HLK is €126.00 and 52 week low is €64.80.
When is next earnings date of Krka DD(LTS:0HLK)?
The next earnings date of Krka DD(LTS:0HLK) is .
Does Krka DD(LTS:0HLK) pay dividends? If so, how much?
Krka DD(LTS:0HLK) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers